Krsnaa Diagnostics Intrinsic Value
KRSNAA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹354.24 | ₹283.39 - ₹425.09 | -51.6% | EPS: ₹29.52, Sector P/E: 12x |
| Book Value Method | asset | ₹551.88 | ₹496.69 - ₹607.07 | -24.5% | Book Value/Share: ₹551.88, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹420.00 | ₹378.00 - ₹462.00 | -42.6% | Revenue/Share: ₹525.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹903.78 | ₹813.40 - ₹994.16 | +23.6% | EBITDA: ₹252.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹292.54 | ₹234.03 - ₹351.05 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹219.41 | ₹197.47 - ₹241.35 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹243.24 | ₹218.92 - ₹267.56 | -66.7% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹720.00 | ₹648.00 - ₹792.00 | -1.6% | ROE: 10.9%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹605.44 | ₹544.90 - ₹665.98 | -17.2% | EPS: ₹29.52, BVPS: ₹551.88 |
Want to compare with current market value? Check KRSNAA share price latest .
Valuation Comparison Chart
KRSNAA Intrinsic Value Analysis
What is the intrinsic value of KRSNAA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Krsnaa Diagnostics (KRSNAA) is ₹420.00 (median value). With the current market price of ₹731.35, this represents a -42.6% variance from our estimated fair value.
The valuation range spans from ₹219.41 to ₹903.78, indicating ₹219.41 - ₹903.78.
Is KRSNAA undervalued or overvalued?
Based on our multi-method analysis, Krsnaa Diagnostics (KRSNAA) appears to be trading above calculated value by approximately 42.6%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.46 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.45 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 10.9% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 29.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.66x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Krsnaa Diagnostics
Additional stock information and data for KRSNAA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹24 Cr | ₹-41 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹76 Cr | ₹22 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹128 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2017 | ₹64 Cr | ₹37 Cr | Positive Free Cash Flow | 8/10 |
| March 2016 | ₹-23 Cr | ₹-47 Cr | Negative Cash Flow | 3/10 |